The existence of primary nodal marginal zone lymphomas (MZL) is controversi
al, as is their relationship to putative extranodal counterparts. Most noda
l lymphomas with monocytoid B cell/marginal zone differentiation exhibit th
e morphologic and immunophenotypical characteristics of extranodal MALT-lym
phomas. Splenic marginal zone lymphoma (SMZL) is also of putative marginal
zone derivation, but it differs immunophenotypically from MALT lymphoma. To
clarify the relationship between nodal and extranodal MZLs and to investig
ate the possible existence of a nodal variant of SMZL, 36 MZL initially con
sidered to be primary nodal neoplasms were examined. Other low-grade lympho
mas with marginal zone differentiation were excluded (small lymphocytic lym
phoma/chronic lymphocytic leukemia [SLL/CLL], follicular lymphoma, and mant
le cell lymphoma). Six nodal MZLs showed morphologic and phenotypic charact
eristics similar to those of SMZL, whereas 30 tumors were more similar to M
ALT-type lymphomas. The six tumors with SMZL features showed a polymorphic
infiltrate surrounding residual germinal centers with absent or very attenu
ated mantle cuffs. These lymphomas were IgD positive (6/6) but cyclin D1 (0
/5), CD5 (0/6), and CD23 (0/6) negative. Five of these patients came for tr
eatment in stage I or II. No patient manifested splenomegaly, peripheral bl
ood, and/or bone marrow infiltration either at diagnosis or during follow-u
p. Lymph nodes from 30 patients with MALT-type features showed a perisinuso
idal and perivascular infiltration of monocytoid/centrocytoid cells and res
idual germinal centers with a relatively well-preserved mantle cuff. The ne
oplastic cells were negative for IgD (0/17), cyclin DI (0/8), and CD5 (0/12
). Seven of 16 (44%) patients with a detailed history and clinical follow-u
p had evidence of extranodal lymphoma. These observations suggest that most
nodal B cell lymphomas with marginal zone differentiation are of the MALT
type and that they are frequently associated with an extranodal component I
n addition, a primary nodal counterpart of splenic MZL also exists, and may
occur in the absence of splenomegaly.